VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Vistagen Therapeutics, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.20+0.00 (+1.55%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$1.27MFY2026, -0.4% a year since FY2012